Vycor Medical Inc. (VYCO)
OTCQB OTCQB Primary Summary
Vycor Medical Inc. (VYCO) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Vycor Medical Inc. ever had a stock split?
Vycor Medical Inc. Profile
| Health Care Equipment & Supplies Industry | Healthcare Sector | Peter C. Zachariou CEO | OTCQB Exchange | 92921M203 CUSIP |
| US Country | 7 Employees | - Last Dividend | 15 Jan 2013 Last Split | - IPO Date |
Overview
Vycor Medical, Inc. is a specialized medical device company focusing on the development and commercialization of innovative solutions for neurosurgery and vision rehabilitation. Established in 2005 and headquartered in Boca Raton, Florida, the company operates on a global scale, primarily in the United States and Europe. Vycor's business is structured into two main segments: Vycor Medical and NovaVision. Each segment caters to distinct areas within neurological care, offering products and therapies that address the needs of patients who have suffered from strokes or other brain injuries, as well as supporting professionals in the medical field. Furthermore, Vycor Medical, Inc. maintains a strategic relationship with HelferApp GmbH through a license and transition agreement, enabling the provision of NovaVision's products and therapies in Austria and Switzerland. The company is a subsidiary of Fountainhead Capital Management Limited, indicating its solid backing and operational framework.
Products and Services
- ViewSite Brain Access System - Part of the Vycor Medical segment, this product offers an advanced retraction and access solution designed explicitly for neurosurgery. The ViewSite Brain Access System facilitates safer and more efficient navigation and access during brain and spine surgeries, enabling surgeons to perform procedures with enhanced precision and potentially better outcomes.
- Computer-based Vision Rehabilitation Therapies - Offered through the NovaVision segment, these non-invasive, computer-based therapies are targeted at individuals who have experienced vision impairment due to stroke or other brain injuries. The therapies leverage visual exercises and tasks to stimulate the brain's ability to compensate for lost vision, aiming to improve visual functions and the quality of life for patients. Vycor's partnership with HelferApp GmbH extends the availability of these therapies to patients and professionals in Austria and Switzerland, further broadening the impact of NovaVision's innovative solutions.
